Quantcast
Channel: DR ANTHONY MELVIN CRASTO Ph.D – New Drug Approvals
Viewing all articles
Browse latest Browse all 1640

Oditrasertib

$
0
0
Oditrasertib.png
Structure of Oditrasertib

Oditrasertib

Molecular FormulaC14H15F2N3O2
Molecular Weight295.2846
  • UNII-I1YQT8HC89
  • I1YQT8HC89
  • cas 2252271-93-3
  • 4-(3,3-Difluoro-2,2-dimethylpropanoyl)-3,5-dihydro-2H-pyrido(3,4-F)(1,4)oxazepine-9-carbonitrile

PYRIDO(3,4-F)-1,4-OXAZEPINE-9-CARBONITRILE, 4-(3,3-DIFLUORO-2,2-DIMETHYL-1-OXOPROPYL)-2,3,4,5-TETRAHYDRO-

Oditrasertib is a serine/threonine kinase (STK) inhibitor.

PATENT

[WO2018213632A1]

https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2018213632

str1
Flag Counter

AS ON DEC2021 3,491,869 VIEWS ON BLOG WORLDREACH AVAILABLEFOR YOUR ADVERTISEMENT

wdt-16

join me on Linkedin

Anthony Melvin Crasto Ph.D – India | LinkedIn

join me on Researchgate

RESEARCHGATE

This image has an empty alt attribute; its file name is research.jpg

join me on Facebook

Anthony Melvin Crasto Dr. | Facebook

join me on twitter

Anthony Melvin Crasto Dr. | twitter

+919321316780 call whatsaapp

EMAIL. amcrasto@gmail.com

//////////

///////////Oditrasertib,

CC(C)(C(F)F)C(=O)N1CCOC2=C(C=NC=C2C1)C#N


Viewing all articles
Browse latest Browse all 1640

Trending Articles